BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38255096)

  • 1. Unlicensed/Off-Label Drug Prescriptions at Hospital Discharge in Children: An Observational Study Using Routinely Collected Health Data.
    Jaberi E; Boussaha I; Dode X; Grenet G; Kassai B; Nguyen KA
    Healthcare (Basel); 2024 Jan; 12(2):. PubMed ID: 38255096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
    Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
    Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Justification of off-label antibiotics uses in hospitalized children].
    Berthod C; Kassaï B; Boussageon R; ; Adelaide L; Jacquet-Lagrèze M; Lajoinie A
    Therapie; 2017 Dec; 72(6):649-658. PubMed ID: 28647107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-label and unlicensed medicine prescribing in university hospital paediatric wards in Finland: A prospective study.
    Kaisto H; Sepponen K; Lindell-Osuagwu L; Sankilampi U
    Br J Clin Pharmacol; 2023 Aug; 89(8):2592-2602. PubMed ID: 36998116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
    Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
    Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Unlicensed and Off-label Prescription of Medications in General Paediatric Ward: An Observational Study.
    Dornelles AD; Calegari LH; de Souza L; Ebone P; Tonelli TS; Carvalho CG
    Curr Pediatr Rev; 2019; 15(1):62-66. PubMed ID: 30421680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-label and unlicensed drug use in children admitted to Pediatric Intensive Care Units (PICU).
    Jobanputra N; Save SU; Bavdekar SB
    Int J Risk Saf Med; 2015; 27(3):113-21. PubMed ID: 26410245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Off-label and unlicensed drug use in children population.
    Moulis F; Durrieu G; Lapeyre-Mestre M
    Therapie; 2018 Apr; 73(2):135-149. PubMed ID: 29580614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of off-label and unlicensed drugs in the neonatal intensive care unit and its association with severity scores.
    Carvalho CG; Ribeiro MR; Bonilha MM; Fernandes M; Procianoy RS; Silveira RC
    J Pediatr (Rio J); 2012; 88(6):465-70. PubMed ID: 23108602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-label and unlicensed medication use and associated adverse drug events in a pediatric emergency department.
    Phan H; Leder M; Fishley M; Moeller M; Nahata M
    Pediatr Emerg Care; 2010 Jun; 26(6):424-30. PubMed ID: 20502385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of unlicensed drugs in a Swiss Pediatric University Hospital and associated prescribing error rates - a retrospective observational study.
    Satir A; Pfiffner M; Meier CR; Caduff Good A
    Swiss Med Wkly; 2024 Mar; 154():3369. PubMed ID: 38579321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
    Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
    Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off-label and unlicensed drug use in a pediatric intensive care unit of a tertiary care Spanish hospital. A descriptive study.
    Camacho Arroyo MT; Rivas Paterna AB; Meneses Monroy A; Cabrera García L; Blázquez González P; Mancebo Salas N; Rodríguez Leal L; Vargas Castrillón E
    Arch Argent Pediatr; 2023 Feb; 121(1):e202102550. PubMed ID: 36194689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-label and unlicensed medicines to hospitalised children in Norway.
    Teigen A; Wang S; Truong BT; Bjerknes K
    J Pharm Pharmacol; 2017 Apr; 69(4):432-438. PubMed ID: 27334565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature.
    Lindell-Osuagwu L; Korhonen MJ; Saano S; Helin-Tanninen M; Naaranlahti T; Kokki H
    J Clin Pharm Ther; 2009 Jun; 34(3):277-87. PubMed ID: 19650250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric off-label and unlicensed prescribing in primary care in Malta: Prospective observational drug utilisation study.
    Ellul IC; Grech V; Attard-Montalto S
    Int J Risk Saf Med; 2015; 27(3):123-34. PubMed ID: 26410246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative assessment of off-label and unlicensed drug prescription in neonatal intensive care: FDA versus Brazilian guidelines].
    Costa HTML; Florencio AP; Bezerra PKDV; Cavalcanti JEC; Costa TX; Fernandes FEM; Martins RR
    An Pediatr (Engl Ed); 2021 Mar; 94(3):153-160. PubMed ID: 33514478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands.
    't Jong GW; van der Linden PD; Bakker EM; van der Lely N; Eland IA; Stricker BH; van den Anker JN
    Eur J Clin Pharmacol; 2002 Jul; 58(4):293-7. PubMed ID: 12136376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent, reasons and consequences of off-labeled and unlicensed drug prescription in hospitalized children: a narrative review.
    Shuib W; Wu XY; Xiao F
    World J Pediatr; 2021 Aug; 17(4):341-354. PubMed ID: 34080130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for unlicensed and off-label drug use in children outside the hospital.
    Schirm E; Tobi H; de Jong-van den Berg LT
    Pediatrics; 2003 Feb; 111(2):291-5. PubMed ID: 12563053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.